CXHL2300027 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2023-01-07 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHL2300026 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2023-01-07 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHL2300025 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2023-01-07 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHL2300024 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2023-01-07 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHL2100073 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
CXHL2100072 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
CXHL2100071 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | New Drug Application | 2021-01-29 | 信达生物制药(苏州)有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-28 | view |
CXHB2200033 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHB2200032 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHB2200031 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHB2200030 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHB2200029 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
CXHB2200028 | IBI362注射液 | mazdutide | Injection | Chemical Drugs(1) | Supplementary Application | 2022-03-09 | | Innovent Biologics (Suzhou) Co Ltd | | | view |